메뉴 건너뛰기




Volumn 90, Issue 2, 2003, Pages 252-259

Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis

Author keywords

Deep venous thrombosis; Low molecular weight heparin; Therapy

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; CERTOPARIN; HEMOGLOBIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MONOEMBOLEX;

EID: 12444319316     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH02-09-0061     Document Type: Article
Times cited : (38)

References (24)
  • 1
    • 0033816299 scopus 로고    scopus 로고
    • Low-molecular-weight heparin in the treatment of venous thromboembolism
    • Hull RD, Pineo GF. Low-molecular-weight heparin in the treatment of venous thromboembolism. Sem Thromb Hemost 2000; 26 (Suppl 1): 61-7.
    • (2000) Sem Thromb Hemost , vol.26 , Issue.SUPPL. 1 , pp. 61-67
    • Hull, R.D.1    Pineo, G.F.2
  • 2
    • 0034707642 scopus 로고    scopus 로고
    • Low-molecular-weight heparin vs. heparin in the treatment of patients with pulmonary embolism
    • Hull RD, Raskob GE, Brant RF, et al. Low-molecular-weight heparin vs. heparin in the treatment of patients with pulmonary embolism. Arch Intern Med 2000; 160: 229-36.
    • (2000) Arch Intern Med , vol.160 , pp. 229-236
    • Hull, R.D.1    Raskob, G.E.2    Brant, R.F.3
  • 3
    • 0034264161 scopus 로고    scopus 로고
    • Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism
    • Merli GJ. Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism. Am J Phys Med Rehabil 2000; 79 (Suppl): S9-S16.
    • (2000) Am J Phys Med Rehabil , vol.79 , Issue.SUPPL.
    • Merli, G.J.1
  • 4
    • 0032745736 scopus 로고    scopus 로고
    • Differentiation of low molecular weight heparins in treatment of acute deep vein thrombosis
    • Davidson BL. Differentiation of low molecular weight heparins in treatment of acute deep vein thrombosis. Sem Thromb Hemost 1999; 25 (Suppl 3): 107-12.
    • (1999) Sem Thromb Hemost , vol.25 , Issue.SUPPL. 3 , pp. 107-112
    • Davidson, B.L.1
  • 5
    • 0031755859 scopus 로고    scopus 로고
    • Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis
    • Kirchmaier CM, Wolf H, Schäfer H, Ehlers B, Breddin HK. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Int Angiol 1998; 17: 135-45.
    • (1998) Int Angiol , vol.17 , pp. 135-145
    • Kirchmaier, C.M.1    Wolf, H.2    Schäfer, H.3    Ehlers, B.4    Breddin, H.K.5
  • 6
    • 0034020857 scopus 로고    scopus 로고
    • Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis
    • Harenberg J, Schmidt JA, Koppenhagen K, Tolle A, Huisman MV and the EASTERN Investigators. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. Thromb Haemost 2000; 83: 652-6.
    • (2000) Thromb Haemost , vol.83 , pp. 652-656
    • Harenberg, J.1    Schmidt, J.A.2    Koppenhagen, K.3    Tolle, A.4    Huisman, M.V.5
  • 7
    • 0034776652 scopus 로고    scopus 로고
    • Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with fixed-dose body weight-independent low-molecular-weight heparin certoparin
    • Harenberg J, Huisman MV, Tolle AR, Breddin HK, Kirchmaier CM. Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with fixed-dose body weight-independent low-molecular-weight heparin certoparin. Semin Thromb Hemost 2001; 27: 513-8.
    • (2001) Semin Thromb Hemost , vol.27 , pp. 513-518
    • Harenberg, J.1    Huisman, M.V.2    Tolle, A.R.3    Breddin, H.K.4    Kirchmaier, C.M.5
  • 8
    • 0028619850 scopus 로고
    • Evaluation of experiments with adaptive interim analyses
    • Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50: 1029-41.
    • (1994) Biometrics , vol.50 , pp. 1029-1041
    • Bauer, P.1    Köhne, K.2
  • 9
    • 0020308864 scopus 로고
    • Proving the null hypothesis in clinical trials
    • Blackwelder WC. Proving the null hypothesis in clinical trials. Control Clin Trials 1982; 3: 345-53.
    • (1982) Control Clin Trials , vol.3 , pp. 345-353
    • Blackwelder, W.C.1
  • 10
    • 0021323563 scopus 로고
    • Repeated confidence intervals for group sequential clinical trials
    • Jennison C, Turnbull BW. Repeated confidence intervals for group sequential clinical trials. Control Clin Trials 1984; 5: 33-45.
    • (1984) Control Clin Trials , vol.5 , pp. 33-45
    • Jennison, C.1    Turnbull, B.W.2
  • 12
    • 0034667833 scopus 로고    scopus 로고
    • For the initial treatment of venous thromboembolism: Are all low-molecular-weight heparin compounds the same?
    • Van Der Heijden JF, Prins MH, Büller HR. For the initial treatment of venous thromboembolism: Are all low-molecular-weight heparin compounds the same? Thromb Res 2000; 100: V121-V30.
    • (2000) Thromb Res , vol.100
    • Van Der Heijden, J.F.1    Prins, M.H.2    Büller, H.R.3
  • 13
    • 0034667831 scopus 로고    scopus 로고
    • Low molecular weight heparins: Are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis
    • Boneu B. Low molecular weight heparins: Are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis. Thromb Res 2000, 100: 113-20.
    • (2000) Thromb Res , vol.100 , pp. 113-120
    • Boneu, B.1
  • 14
    • 0034707685 scopus 로고    scopus 로고
    • A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism
    • Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism. Arch Intern Med 2000, 160: 181-8.
    • (2000) Arch Intern Med , vol.160 , pp. 181-188
    • Dolovich, L.R.1    Ginsberg, J.S.2    Douketis, J.D.3    Holbrook, A.M.4    Cheah, G.5
  • 15
    • 0033790854 scopus 로고    scopus 로고
    • Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis
    • Rocha E, Martinez-Gonzalez MA, Montes R, Panizo C. Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis. Haematologica 2000; 85: 935-42.
    • (2000) Haematologica , vol.85 , pp. 935-942
    • Rocha, E.1    Martinez-Gonzalez, M.A.2    Montes, R.3    Panizo, C.4
  • 16
    • 84921431248 scopus 로고    scopus 로고
    • Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
    • Van Den Belt AGM, Prins MH, Lensing AWA, et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Library Syst Rev 2000; 1: 1-18.
    • (2000) Cochrane Library Syst Rev , vol.1 , pp. 1-18
    • Van Den Belt, A.G.M.1    Prins, M.H.2    Lensing, A.W.A.3
  • 17
    • 0035283104 scopus 로고    scopus 로고
    • Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis
    • Breddin HK, Hach-Wunderle V, Nakov R, Kakkar VV for the CORTES Investigators. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001; 344: 626-31.
    • (2001) N Engl J Med , vol.344 , pp. 626-631
    • Breddin, H.K.1    Hach-Wunderle, V.2    Nakov, R.3    Kakkar, V.V.4
  • 18
    • 0033610234 scopus 로고    scopus 로고
    • Recurrent venous thrombosis and heparin therapy: An evaluation of the importance of early activated partial thromboplastin times
    • Anand SS, Bates S, Ginsberg JS, et al. Recurrent venous thrombosis and heparin therapy: An evaluation of the importance of early activated partial thromboplastin times. Arch Intern Med 1999; 159: 2029-32.
    • (1999) Arch Intern Med , vol.159 , pp. 2029-2032
    • Anand, S.S.1    Bates, S.2    Ginsberg, J.S.3
  • 19
    • 0026631285 scopus 로고
    • The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model
    • Bacher P, Welzel D, Iqbal O, et al. The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model. Thromb Res 1992; 66: 151-8.
    • (1992) Thromb Res , vol.66 , pp. 151-158
    • Bacher, P.1    Welzel, D.2    Iqbal, O.3
  • 20
    • 0028267616 scopus 로고
    • Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin. Results of a pilot study
    • Kirchmaier CM, Lindhoff-Last E, Rübesam D, et al. Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin. Results of a pilot study. Thromb Res 1994; 73: 337-48.
    • (1994) Thromb Res , vol.73 , pp. 337-348
    • Kirchmaier, C.M.1    Lindhoff-Last, E.2    Rübesam, D.3
  • 21
    • 0029842386 scopus 로고    scopus 로고
    • Once-daily subcutaneous Dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis
    • Fiessinger JN, Lopez-Fernandez M, Gatterer E, et al. Once-daily subcutaneous Dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis. Thromb Haemost 1996; 76: 195-9.
    • (1996) Thromb Haemost , vol.76 , pp. 195-199
    • Fiessinger, J.N.1    Lopez-Fernandez, M.2    Gatterer, E.3
  • 22
    • 0031955043 scopus 로고    scopus 로고
    • Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis
    • Charbonnier BA, Fiessinger J-N, Banga JD, Wenzel E, D'Azemar P, Sagnard L. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. Thromb Haemost 1998, 79: 897-901.
    • (1998) Thromb Haemost , vol.79 , pp. 897-901
    • Charbonnier, B.A.1    Fiessinger, J.-N.2    Banga, J.D.3    Wenzel, E.4    D'Azemar, P.5    Sagnard, L.6
  • 23
    • 0035814834 scopus 로고    scopus 로고
    • Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease
    • Merli G, Spiro TE, Olsson C-G, et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med 2001; 134: 191-202.
    • (2001) Ann Intern Med , vol.134 , pp. 191-202
    • Merli, G.1    Spiro, T.E.2    Olsson, C.-G.3
  • 24
    • 0034756458 scopus 로고    scopus 로고
    • Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism. A meta-analysis
    • Couturaud F, Julian JA, Kearon C. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism. A meta-analysis. Thromb Haemost 2001, 86: 980-4.
    • (2001) Thromb Haemost , vol.86 , pp. 980-984
    • Couturaud, F.1    Julian, J.A.2    Kearon, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.